OConnell Daniel Joseph
SEC CIK 1865136 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals, Inc. | Pres, CEO, Dir | 881.3K | — | $324.0K | 14 | 2021-07-06 | 2026-01-21 |
Most active insiders at ABOS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meisner Derek M | CLO, Corp Sec | — | $248.8K |
| 2 | OConnell Daniel Joseph | CEO, Dir | — | $163.2K |
| 3 | Porter Derrell | Dir | — | $75.2K |
| 4 | Zuga Matt | CFO, Chief Business Off | — | $49.6K |
| 5 | Barton Russell | COO | — | $30.0K |
| 6 | Siemers Eric | Chief Medical Off | — | $27.1K |
| 7 | Doherty James J. | Pres, CDO | — | $15.2K |
| 8 | Fountain Nathan B | Dir | — | $14.3K |
| 9 | Schacterle Amy | Chief Regulatory Off | — | $2,172 |
| 10 | Stoppel Laura | Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-23 | 2026-01-21+ | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | CEO, Dir | S - Sale | $1.83 | -12.0K | 881.3K | -1% | -$22.0K |
| D | 2026-01-21 | 2026-01-20 | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | CEO, Dir | A - Grant | $0.00 | +299.8K | 893.3K | +51% | $0 |
| M | 2026-01-12 | 2026-01-08+ | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | CEO, Dir | S - Sale | $1.77 | -26.5K | 598.9K | -4% | -$46.9K |
| M | 2026-01-07 | 2026-01-05+ | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | CEO, Dir | S - Sale | $1.99 | -47.5K | 662.8K | -7% | -$94.3K |
| 2025-01-23 | 2025-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | CEO, Dir | S - Sale | $1.59 | -12.6K | 667.5K | -2% | -$20.1K | |
| D | 2025-01-07 | 2025-01-07 | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | CEO, Dir | A - Grant | $0.00 | +225.4K | 680.1K | +50% | $0 |
| D | 2025-01-07 | 2025-01-03 | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | CEO, Dir | S - Sale | $1.84 | -47.8K | 454.7K | -10% | -$87.9K |
| 2024-01-19 | 2024-01-19 | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | Pres, CEO, Dir | S - Sale | $3.47 | -15.2K | 502.5K | -3% | -$52.7K | |
| D | 2024-01-04 | 2024-01-02 | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | Pres, CEO, Dir | A - Grant | $0.00 | +401.0K | 517.7K | +344% | $0 |
| D | 2023-01-18 | 2023-01-17 | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | Pres, CEO, Dir | A - Grant | $0.00 | +114.0K | 116.7K | +4,246% | $0 |
| D | 2021-12-02 | 2021-11-30 | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | Pres, CEO, Dir | M - OptEx | $4.47 | +1,118 | 2,685 | +71% | +$4,997 |
| D | 2021-07-08 | 2021-07-06 | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | Pres, CEO, Dir | X - OptEx | $4.47 | +35 | 1,577 | +2% | +$156.45 |
| D | 2021-07-08 | 2021-07-06 | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | Pres, CEO, Dir | C - Cnv Deriv | — | +123 | 1,542 | +9% | — |
| D | 2021-07-08 | 2021-07-06 | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | Pres, CEO, Dir | F - Tax | $16.00 | -10 | 1,567 | -0.6% | -$160 |
Purchase Sale Sale after option exercise All abbreviations